New type 1 diabetes therapy shows promise for long-term reversal in both humans, dogs
No more pumps? No more daily insulin shots? A collagen formulation mixed with pancreatic cells, developed by Purdue University researchers in collaboration with the Indiana University School of Medicine, is the first minimally invasive therapy to successfully reverse Type 1 diabetes within 24 hours and maintain insulin independence for at least 90 days, a pre-clinical animal study shows.